• Bufalin: Redefining Triple-Negative Breast Cancer Targets

  2026-05-27

  Bufalin, a cardiotonic steroid, is shifting the paradigm in triple-negative breast cancer (TNBC) research by acting as both a targeted apoptosis inducer and a molecular glue degrader. This article delves into the mechanistic basis for Bufalin’s unique bioactivities—highlighting its newly validated role in STK33 degradation—while offering strategic protocol guidance and translational insights for oncology investigators. We contextualize these advances within the competitive landscape and present a forward-looking outlook on Bufalin’s prospects in translational cancer research.

• Dextromethorphan Hydrobromide: Neuroprotection, Ion Channel

  2026-05-27

  Explore the multifaceted role of Dextromethorphan hydrobromide as an NMDA receptor antagonist, focusing on ion channel modulation, neuroprotection, and translational implications for cerebral ischemia and Alzheimer's research. This article delivers deeper mechanistic insights and practical guidance beyond standard protocol summaries.

• Meropenem Trihydrate: Advanced Workflows for Resistance Rese

  2026-05-26

  Meropenem trihydrate empowers modern microbiology with reliable, water-soluble dosing and robust inhibition of multidrug-resistant bacteria. Leveraging metabolomics-driven insights, researchers can now accelerate phenotype-based antibiotic resistance studies and streamline detection of carbapenemase-producing pathogens. Discover actionable protocol enhancements and troubleshooting strategies that set APExBIO's offering apart.

• CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce

  2026-05-26

  The CFDA SE Cell Tracer Kit addresses the need for robust, long-term covalent fluorescent labeling in cell proliferation and lineage tracing workflows. It is best suited for applications requiring durable, persistent tracking of cell populations, and should not be used for workflows demanding reversible or short-term cell labeling.

• Blocking Extracellular Vesicle Release in Triple-Negative Br

  2026-05-25

  McNamee et al. provide a systematic evaluation of inhibitors targeting extracellular vesicle (EV) release in triple-negative breast cancer (TNBC), revealing that near-complete EV suppression is necessary to curtail the transmission of aggressive cancer traits. This work establishes foundational protocols for EV modulation and informs future strategies in cancer cell communication research.

• Prednisone as a Translational Lever: Mechanism, Modeling, an

  2026-05-25

  This thought-leadership article unpacks the mechanistic depth and translational strategy behind Prednisone, a synthetic corticosteroid, as an advanced research tool. By bridging molecular mechanisms with bench-to-bedside assay design and integrating comparative perspectives from botanical modeling, we provide actionable guidance for researchers navigating immunology, neurodegeneration, and model optimization. This article builds on—but distinctly advances beyond—conventional product listings by contextualizing APExBIO’s Prednisone within current challenges and opportunities in translational research.

• ML385: A Selective NRF2 Inhibitor for Cutting-Edge Research

  2026-05-24

  ML385 empowers researchers to dissect NRF2-mediated antioxidant and resistance mechanisms with high specificity, driving breakthroughs in cancer, oxidative stress, and ferroptosis research. Recent in vivo studies validate its translational potential and provide actionable parameters for robust experimental design.

• Pregnenolone Carbonitrile: Optimizing Rodent PXR Assays

  2026-05-23

  Pregnenolone Carbonitrile enables precise control of rodent PXR activation for robust CYP3A induction and antifibrotic studies. Recent advances show gut microbiota is pivotal in mediating its hepatoprotective effects, reshaping experimental workflows for liver injury and xenobiotic metabolism research.

• CHIR-99021 (CT99021): Optimizing Stem Cell and Differentiati

  2026-05-22

  CHIR-99021 (CT99021) empowers researchers to reliably maintain pluripotency, direct lineage specification, and dissect Wnt/β-catenin and TGF-β/Nodal signaling with unparalleled selectivity. This article translates bench research and recent breakthroughs into actionable steps, unlocking advanced stem cell and disease modeling applications.

• Vancomycin Hydrochloride in Advanced Antibiotic Resistance A

  2026-05-22

  Vancomycin hydrochloride empowers precise, reproducible workflows for studying Gram-positive bacterial inhibition and antibiotic resistance profiling. This article connects cutting-edge animal model research with practical laboratory protocols, spotlighting real-world troubleshooting strategies for robust outcomes.

• Bifendate (DDB): Unraveling Dose-Dependent Lipid and Hepatic

  2026-05-21

  Explore how bifendate (DDB) acts as a hepatoprotection agent with nuanced dose-dependent impacts on lipid metabolism and autophagy. This in-depth review clarifies mechanistic findings and practical protocols, revealing applications and limitations overlooked elsewhere.

• Pharmacokinetics of Corydalis Alkaloids in MASH: Mechanisms

  2026-05-21

  This study systematically analyzes the pharmacokinetic variability and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal how disease state and transporter/enzyme expression shape systemic exposure and liver accumulation of key alkaloids, informing rational dosing strategies for MASLD/MASH therapies.

• Hoechst 33258: Optimizing Bis-Benzimide DNA Staining Workflo

  2026-05-20

  Hoechst 33258 is a gold-standard bis-benzimide DNA stain, enabling high-fidelity DNA visualization in live and fixed cells—even under challenging tumor microenvironment conditions. This guide covers practical protocols, advanced cell cycle and tumor pH studies, and troubleshooting tips, drawing on the latest chemo-immunotherapy innovations.

• Naloxone Hydrochloride: Redefining Opioid Antagonism in Tran

  2026-05-20

  Naloxone hydrochloride, widely recognized as a life-saving opioid overdose reversal agent, has emerged as an essential probe for translational researchers seeking to unravel the complexities of opioid receptor signaling, neural stem cell modulation, and immune function. This thought-leadership article blends mechanistic insight with practical guidance, positioning APExBIO’s high-purity Naloxone (hydrochloride) as a cornerstone reagent for preclinical and translational workflows. By exploring advanced applications, competitive landscape, and future directions, this piece provides actionable intelligence and strategic context for the next generation of addiction, neuroregeneration, and immune modulation studies.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui

  2026-05-19

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe (SKU B8804) addresses the need for robust, selective plasma membrane labeling in both live and fixed cell workflows, including neuronal tracing and migration analysis. It should not be used for aqueous staining protocols or for exclusive cytoplasmic or organelle labeling, as its performance and specificity depend on membrane compatibility and correct solvent handling.

406 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page